Definitive Contract HHSN261200577004C
Award Date 9/30/05
Potential Completion Date 3/31/07
Potential Value $747K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
The Woodlands, TX 77380, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with the ID HHSN261201400038C, was issued by the National Cancer Institute, a civilian agency, to Synergene Therapeutics Inc., a for-profit organization. The contract is for research and development in the medical and biomedical (basic research) domain, with a firm fixed price of $222,900.00 and a completion date of June 14, 2015. The contract was awarded on September 15, 2014 and did not have a set-aside designation. The contract appears to be a standalone award,...
- This federal contract award, valued at $141,905.45, was issued by the National Cancer Institute (NCI) to the small business contractor Synergy Enterprises, Inc. The contract is for Task Order 5: Contract Management and Monitoring, and has an ultimate completion date of August 29, 2024. Synergy Enterprises is a minority-owned, woman-owned small business based in Rockville, Maryland that specializes in providing professional services to federal agencies, particularly in the areas of education,...
- Synergy Enterprises, Inc., a woman-owned small business, was awarded a $47,357.51 Firm Fixed Price delivery order contract by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services. The contract supports the NCI Global Cancer Research and Control Seminar Series (GCRCSS) program, with a period of performance through September 2023. Synergy Enterprises is an experienced federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with...
- The federal contract award HHSN261200700013C, valued at $749,438.00, was issued by the National Cancer Institute (NCI), a civilian agency, to Scientific Software International, Inc. (SSI) under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of an Outcomes Research System called "OTHER FUNCTIONS MEDPRO" and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract has a total small business set-aside designation...
- This is a $109,166.94 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Synergy Enterprises, Inc., a woman-owned small business located in Silver Spring, Maryland. The contract is for a 2021 Global Oncology Survey of NCI-Designated Cancer Centers. The contract does not have a set-aside designation. Synergy Enterprises is a minority-owned, woman-owned small business that provides professional services for federal agencies, particularly in the areas of...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Synergy Enterprises, Inc., a woman-owned small business. The $29,676.30 contract is for an annual principal investigator (PI) meeting for the "IMPLEMENTATION SCIENCE FOR CANCER CONTROL IN PEOPLE LIVING WITH HIV IN LMICS U01" program, which aims to support research on implementing cancer control interventions in low- and...
- <p>This is a $13,290,090.00 cost-no-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Alnis Biosciences Incorporated for the development of "NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS, AND TREATMENT OF CANCER." The contract was awarded on September 30, 2004 with a period of performance ending on March 31, 2008. This contract does not have a set-aside designation.</p>
- This is a federal contract award from the National Cancer Institute, a civilian agency, to provide STATE CANCER POLICY DATABASE SUPPORT SERVICES. The contract has a ceiling value of $29,543,490.00 and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The award was made on September 15, 2002 with a completion date of September 15, 2007. The contract does not have a set-aside designation. The prime contractor is No Data From D And B, and the place of performance is Silver Spring,...
- This is a federal contract award to Cygnus Corp Inc., a woman-owned small business, by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS). The $3,194,234.34 cost-plus-fixed-fee contract is for the provision of other administrative support services. The contract was awarded on March 26, 2002 and has a completion date of July 31, 2007. It was set aside for small businesses. Cygnus Corp Inc. is a company that specializes in providing advanced...
- This is a federal contract award by the National Cancer Institute (NCI), a civilian agency, to Sophic Systems Alliance Inc., a small business veteran-owned contractor. The contract is for a System to Analyze and Support Biomarker Research and Development Strategies under the Small Business Innovation Research (SBIR) Program Phase II. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $745,999.90 and a period of performance ending on August...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to Synergos Incorporated on September 30, 2005. The contract, valued at $747,015.00, is for monitoring, data management, and statistical services for SS1P clinical trials. The contract does not have a set-aside designation and is a cost-no-fee contract type. The ultimate completion date for this contract is March 31, 2007.
Generated 11/21/24, 9:39 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 3 | Funding Only Action | 0$ | 9/22/11 | |
| 2 | Exercise an Option | $82.3k | 9/28/06 | |
| 1 | Exercise an Option | $82.5k | 3/17/06 | |
| Not listed | Not listed | $84.2k | 9/20/05 |